Where does Epitech MAG Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Epitech MAG Ltd. ranks #46,547 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Epitech MAG Ltd. hold?

Epitech MAG Ltd. holds 5 US utility patents granted between 2021 and 2024, spanning 3 technology areas.

What is Epitech MAG Ltd.'s Innovation Score?

Epitech MAG Ltd. has an Innovation Score of 31.3 out of 100 (37th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Epitech MAG Ltd. focus on?

Epitech MAG Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 5 patents, ranking #681 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Epitech MAG Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Epitech MAG Ltd..

What does claim depth mean for Epitech MAG Ltd.'s patents?

Epitech MAG Ltd.'s patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Epitech MAG Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Epitech MAG Ltd.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Epitech ranks #46,547 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#46,547
of 49,997 US assignees by volume: 37th percentile
by Innovation Score (31.3/100): 15.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R46547 · Foreign Corporation #46,547 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,547/49,997
PHOTO-FINISH Epic Medical PTE
CPC-NARROW A61N · 3 areas
INNOV-THIN 31.3/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2024 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Epic Medical PTE. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Epitech’s 31.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (20%) Velocity 10.0 pts (32%) Breadth 6.1 pts (19%) Claim depth 9.0 pts (29%)

Qualcomm Incorporated · highest

85
Epitech MAG · this assignee

31
3D Lighting… · lowest

7

What this shows Epitech's Innovation Score is 31.3/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Epitech?

Each dot is one of Epitech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Epitech’s own 15.0 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Epitech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Epitech's grants concentrate

Epitech MAG Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2022. By volume, Epitech sits between Epic Medical PTE. Ltd. and Ernst Grob AG.

Epitech's three-year grant acceleration

Epitech MAG Ltd. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Epic Medical PTE

5
Epic Sciences

5
Epigan

5
Epimmune

5
Equus UK Topco

5
Era3

5
Ergo Exergy

5
Ernst Grob

5
Epitech MAG ◀

5

What this shows Epitech holds 5 patents at rank #46,448, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Epitech

By rank, the assignees closest to #46,448 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Epitech's primary technology class.

Epitech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Epitech MAG Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	40.0%
2022	1	20.0%
2024	2	40.0%

Which technologies does Epitech MAG Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Epitech MAG Ltd.'s patent record in context - here's where to go next.

Epitech MAG Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #46,547 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Epitech MAG Ltd. against Epic Medical PTE. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.